[Development and characteristics of a moxa floss shaping and spreading device].

This paper introduces a moxa floss shaping and spreading device for governor vessel moxibustion. This device is consisted of a storage unit and a propulsion unit, capable of automatically shaping moxa sticks for governor vessel moxibustion. The device allows for the flexible adjustment of moxa stick length, better conforming to the physiological curvature of the spine, and avoiding potential burns associated with governor vessel moxibustion. It simplifies the operational procedures for healthcare professionals, offering the advantages of ease of use, safety, and efficiency.

Efficacy of warming needle moxibustion in the treatment of ankylosing spondylitis: A protocol of a randomized controlled trial.

BACKGROUND: Ankylosing spondylitis is a recurrent autoimmune disease, which has a high disability rate and seriously affects patients' daily life. Conventional treatment cannot effectively solve the clinical problems of patients, and long-term medication is accompanied by adverse reactions. The evidence shows that warming needle moxibustion has advantages in the treatment of ankylosing spondylitis, but there is still a lack of clinical studies on warm acupuncture alone and long-term follow-up. METHODS: This is a prospective randomized controlled trial to study the efficacy and safety of needle warming through moxibustion in the treatment of ankylosing spondylitis. It was approved by the Ethics Committee of Clinical Research of our hospital. Patients were randomly assigned to an observation group or a control group. The patients were followed up for 6 months after 30 days of treatment. Observation indicators include; activity index, functional ability, Bath Ankylosing Spondylitis Metrology Index, inflammatory indicators, adverse reactions, and so on. Finally, SPASS 22.0 software is used for statistical analysis of the data. DISCUSSION: This study will evaluate the clinical efficacy of warming needle moxibustion in the treatment of ankylosing spondylitis. The results of this study will provide a reference basis for the clinical use of warm needle moxibustion in the treatment of ankylosing spondylitis. TRIAL REGISTRATION: OSF Registration number: DOI 10.17605/OSF.IO/GWPX3.

Quality of moxa wool contained in commercial moxibustion devices: test method and examples of waste particle concentration.

BACKGROUND: Moxibustion treatment involves a combination of thermal and chemical stimulation applied by the combustion of moxa wool. The quality of moxa wool is considered to be an important factor in moxibustion treatment traditionally and clinically. However, despite its importance, quantitative and objective methods for determining moxa wool quality are lacking. METHODS: Moxa wool and commercial indirect moxibustion (CIM) device specimens were randomly collected, dried and strained through sieves of various sizes for 10 h. After sieving, the residues remaining on each sieve were collected. The collected samples were weighed and microscopically observed. RESULTS: In this study, we observed that fibres mainly remained on sieves sized 425 µm, and particles were smaller than 300 µm. The residues between 425 and 300 µm varied between the products. In addition, moxa wool for direct moxibustion (DMW) exhibited significantly more fibres than moxa wool for indirect moxibustion (IMW). Most of the CIM devices using moxa wool had a quality similar to IMW, except for one CIM brand using moxa wool that contained three times more waste particles than IMW. CONCLUSION: Based on the results of this study, we conclude that the sieving method is useful for testing the quality of moxa wool even after the CIM manufacturing process. The sieve sizes of 425 and 300 µm could be used as a yardstick to determine the quality of moxa wool. Although this approach requires larger scale validation against existing standard methodologies, we believe it has great potential to be used to improve and safeguard the quality of moxa wool contained in commercial moxibustion devices.

Moxibustion therapy on myofascial pain syndrome: An evidence-based clinical practice guideline.

BACKGROUND: Myofascial pain syndrome (MPS) is a chronic systemic pain disorder. Among the common treatments, moxibustion has an irreplaceable therapeutic effect and is an effective Traditional Chinese Medicine therapy for MPS. However, the lack of clinical practice guidelines (CPGs) has prompted the publication of guidelines on the use of moxibustion in the treatment of MPS. METHODS: The clinical practice guideline will base on the Institute of Medicine, the World Health Organization guideline handbook, the Grade of Recommendations Assessment, Development, and Evaluation the Appraisal of Guidelines for Research & Evaluation II, Reporting Items for practice, Guideline in Healthcare and recommendations thereof will be made on the basis of systematic reviews. We will establish a guidelines development team that will draft clinical questions in the form of population, intervention, comparison, results and conduct a literature search and quality of evidence assessment. The experts will make recommendations after 2 or 3 rounds of Delphi investigations. We will carefully consider the patient's values and preferences and conduct a peer review. ETHICS AND DISSEMINATION: The guidelines will not contain any personal data and will not prejudice individual rights, so no ethical approval will be required. The guidelines will be subject to rigorous peer review and may be published in a journal or circulated at relevant conferences. RESULTS: The guidelines will be published in relevant peer-reviewed journals. CONCLUSION: This guideline will make it easier for clinicians to treat MPs in the clinical setting and improve the effectiveness of treatment for MPS. STUDY REGISTRATION: The study is registered with the International Practice Guideline Registry Platform (IPGRP): IPGRP-2020CN030.

Effectiveness and safety of electrical moxibustion for knee osteoarthritis: A multicenter, randomized, assessor-blinded, parallel-group clinical trial.

BACKGROUND: The prevalence of knee osteoarthritis (KOA) is increasing, and it has emerged as a major health issue. Studies have been reported that moxibustion is effective for treating KOA, but conventional moxibustion is difficult to control the intensity of stimulation and causes smoke, harmful gases, or odors. An electrical moxibustion (EM) device was developed to solve these problems, so we conducted this study to evaluate the effectiveness and safety of EM as a treatment for KOA. METHODS: This is a multicenter, randomized, assessor-blinded, parallel-group clinical trial. Participants with KOA were randomly allocated into EM, traditional indirect moxibustion (TIM), or usual care groups. The moxibustion groups were received 12 sessions of moxibustion treatment at six acupuncture points (ST36, ST35, ST34, SP9, EX-LE4, SP10) over a period of 6 weeks. The usual care group was received usual treatment and self-care. The primary outcome was the degree of pain measured by numerical rating scale (NRS). The second outcomes were measured using visual analog scale, Korean version of the Western Ontario and McMaster Universities osteoarthritis index, patient global assessment, European quality of life five dimension five level scale, and warm sense threshold and heat pain threshold. For safety assessment, laboratory test and adverse events (AEs) were recorded. RESULTS: A total of 138 participants were assigned. While there was no significant NRS change in the usual care, EM and TIM showed significant decrease after treatment. Compared to the usual care, the mean change of NRS in the EM and TIM was significantly different, but there was no significance between two groups. Regarding secondary outcomes, EM and TIM also showed significant difference compared to the usual care, but there was no significance between two groups. Regarding safety assessment, while usual care showed significant safety among three groups, EM showed seven treatment-related AEs by four participants compared TIM's 10 events by 10 participants. In addition, there was no blister caused by burns in the EM, which occurred four cases in the TIM. CONCLUSION: This study shows that EM is effective to improve the pain and function by KOA with a certain level of safety.

[Design and application of a moxibustion device with separated moxibustion smoke and heat].

In the view of the defects of the commonly used moxibustion instruments and moxa heating instruments, such as the moxa ash cannot be removed automatically, the temperature of moxibustion and moxibustion smoke is difficult to be stabilized and adjusted, and the instruments are complex and expensive, a moxibustion device with separated moxibustion smoke and heat is designed. This device can automatically remove the moxa ash and keep it on the isolation net; the temperature of the moxibustion outlet is maintained at 43-48 ℃ (effective moxibustion temperature) for more than 40 minutes, and there is no visible moxa smoke; the temperature of the moxa smoke outlet is controlled between 28-75 ℃, and the effective discharge of moxa smoke can be realized without external power equipment. This device has the advantages of stable and controllable temperature of moxibustion outlet and moxa smoke outlet, automatic removal and collection of moxa ash, separation of moxa smoke without additional power, etc., which can be used in clinical and animal experiments for moxa heating, moxa smoke removal, etc.

The efficacy of jade moxibustion in knee osteoarthritis.

INTRODUCTION: This study aims to compare clinical effect between Jade moxibustion and traditional moxibustion, and to determine the clinical effect of Jade moxibustion on knee osteoarthritis (KOA). METHODS/DESIGN: This is a 2-parallel-group, randomized controlled trial. A total of 148 subjects with KOA (Kellgren-Lawrence grade II or III) will be recruited and randomized to receive Jade moxibustion treatment or a traditional moxibustion treatment in a 1:1 ratio. Jade moxibustion group: The affected knee of the subjects will be covered with jade kneepad. Traditional moxibustion group: Chosen the ST35, ST34, EX-LE4, SP10 and Ashi points at the affected knee. The subjects will receive treatment three times a week, altogether 12 times in 4 weeks. The main outcomes are WOMAC knee pain score, knee function score and SF-36 quality of life questionnaire changes at the 4th week. Secondary outcomes include WOMAC knee pain score and knee function score, overall clinical efficacy evaluation, medication, safety evaluation at the 2nd, 12th, and 24th week, and cytokines related to osteoarthritis in serum. DISCUSSION: This randomized controlled trial used traditional moxibustion as a control group to provide rigorous evidence for the clinical efficacy and safety of Jade moxibustion in treatment of KOA. TRIAL REGISTRATION: ISRCTN registry, No 21174552. Registered on 28 February 2020.

The Effects of Laser Moxibustion on Knee Osteoarthritis Pain in Rats.

Background: Although chronic pain affects the quality of life of patients with osteoarthritis, current medical treatments are either ineffective or have long-term side effects. Recently, low-intensity laser irradiation of corresponding acupoints was demonstrated to alleviate pain. Objective: The aim of the present study was to investigate the effects of 10.6 µm laser moxibustion on a monosodium iodoacetate (MIA)-induced knee osteoarthritis pain model. Methods: Thirty-two rats were randomly assigned to four groups: Saline, MIA, MIA+Laser, and MIA+Sham Laser. The 10.6 µm laser was used to irradiate the ST35 for 10 min once a day for a total of seven applications. The paw withdrawal mechanical threshold and weight-bearing difference were performed to evaluate the analgesic effects of laser moxibustion. At the end of the experiment on days 28, the joint histology, the levels of metalloproteinases-13 (MMP-13) in the cartilage, and TNF-α, IL-1ß, and IL-6 in the synovial membrane were measured to determine the chondroprotection and anti-inflammatory effect of laser moxibustion. Results: Early laser moxibustion significantly reversed the MIA-induced mechanical hyperalgesia and weight-bearing difference, especially on the 28th day (p < 0.001). Moreover, laser moxibustion prevented the articular pathological lesions and cartilage destruction on days 28 (p < 0.01). Remarkably, the levels of cartilage MMP-13, and synovial TNF-α, IL-1ß, and IL-6 also decreased on day 28 (p < 0.05) after the early treatment of laser moxibustion. Conclusions: 10.6 µm laser moxibustion may have long-lasting analgesic, anti-inflammatory, and chondroprotection effects, suggesting that it may emerge as a potential therapeutic strategy for the chronic pain treatment of osteoarthritis.

[Design of moxibustion device for experimental rabbits].

An experimental device is designed to solve the problem of fixing rabbits and providing moxibustion treatment at the same time. The device includes a rabbit fixing box and a moxibustion shelf. The rabbit fixing box and the moxibustion shelf are detachable, and could be used for moxibustion at the chest-back and abdomen of rabbits. A moxibustion device is placed on the moxibustion shelf. The moxibustion device can be moved forward, backward, leftward, rightward, upward and downward on the moxibustion shelf. It meets the requirements of moxibustion at multiple meridians or acupoints on the chest-back and abdomen at the same time. The moxibustion device is equipped with moxa cone or stick, which not only ensures the full burning of moxa, but also prevents the falling of moxa from hurting rabbits. In conclusion, the device has novel and unique structure, is safe and reliable, and easy to operate. It is an innovation in the experimental device of moxibustion, which could promote the animal experiment of moxibustion.

Acupuntura y moxibustión para embarazadas con presentación no cefálica. Estrategias de intervención y revisión de la literatura / Acupuncture and moxibustion for pregnant women with non-cephalic presentation. Intervention strategies and literature review

Objetivo: Realizar una evaluación de la evidencia científica publicada y explorar las estrategias e intervenciones más adecuadas en la presentación no cefálica con acupuntura o moxibustión. Método: Búsqueda bibliográfica realizada entre los años 2003 y 2018 con las palabras clave «acupuntura», «moxibustión», «presentación de nalgas» y «presentación no cefálica» en las bases de datos PubMed, Cinahl, WoS, Medline y CENTRAL. Resultados: Finalmente se seleccionaron 15 artículos que cumplían con los criterios de inclusión. La moxibustión es eficaz para conseguir la versión a cefálica en las embarazadas con feto en presentación no cefálica en el tercer trimestre de gestación. Los países asiáticos son los que obtienen resultados con mayor éxito (96,7%), respecto a los países occidentales (53,6-75,4%). Discusión: La revisión de la bibliografía nos ofrece una buena evidencia científica en relación con la efectividad de la moxibustión en el punto de acupuntura V67, en la versión del feto a una presentación cefálica. En la gran mayoría de los estudios se ha observado una mejora en la versión del feto en los grupos que aplicaron la técnica de moxibustión en V67 respecto al grupo control, en que no se había aplicado la técnica. Conclusión: En la actualidad, el uso de la moxibustión para la versión cefálica de una presentación no cefálica es un procedimiento de interés tanto para los profesionales sanitarios como para las gestantes, ya que es una técnica efectiva, segura y de fácil aplicación

Objective: To carry out an evaluation of the published scientific evidence and to explore the most appropriate strategies and interventions in the non-cephalic presentation with acupuncture or moxibustion. Method: Bibliographic search was carried out between 2003 and 2018 with the keywords «acupuncture», «moxibustion», «breech presentation», «non-cephalic presentation», in the databases PubMed, Cinahl, WoS, Medline and CENTRAL. Results: Finally, 15 articles were selected that met the inclusion criteria. Moxibustion is effective to achieve the cephalic version in pregnant women with a fetus in non-cephalic presentation in the third trimester of pregnancy. The Asian countries have the most successful results (96.7%) in relation to those in the West (between 53.6 and 75.4%). Discussion: The review of the literature offers us good scientific evidence regarding the effectiveness of moxibustion in V67, in the fetus version of a cephalic presentation. In the vast majority of studies, an improvement in the version of the fetus was observed in the groups that applied the moxibustion technique in V67 in relation to the control group, which had not applied the technique. Conclusion: At present, the use of moxibustion for the cephalic version of a non-cephalic presentation is a procedure of interest for health workers and pregnant women, since it is an effective, safe and easy to apply technique whenever it is indicated

Efficacy and safety of electrical moxibustion for knee osteoarthritis: study protocol for a randomized controlled trial.

BACKGROUND: Knee osteoarthritis (KOA) is a significant health issue because it causes pain and functional limitation. Many studies have reported that moxibustion, a treatment in traditional Korean medicine, is effective in treating KOA. However, conventional moxibustion produces smoke, harmful gases, and odors that can adversely affect the eyes, skin, and throat. It is also difficult to control the intensity of stimulation in conventional moxibustion. An electrical moxibustion device was developed to circumvent these problems, but there are few studies of that device. We will evaluate the efficacy and safety of electrical moxibustion as a treatment for KOA, and compare it with traditional indirect moxibustion and usual care. METHODS: This is a multicenter, randomized, open, assessor-blinded, parallel-group clinical trial. A total of 138 eligible participants with KOA will be randomly allocated into three groups (electrical moxibustion, traditional indirect moxibustion, or usual care) with a 1:1:1 ratio. Participants in each moxibustion group will receive 12 sessions of moxibustion treatment at 6 acupoints (ST36, ST35, ST34, SP9, EX-LE4, SP10) plus up to 2 points of "ashi", if needed, over a period of 6 weeks (2 sessions per week). A specifically designed device that provides thermal stimulation using electrical energy will be used for the electrical moxibustion group. Participants in the usual care group will receive usual treatment and self-care. The primary outcome measure is change in pain on a numerical rating scale (NRS) from week 1 to week 6. The secondary outcome measures are pain assessed on a visual analog scale (VAS), the Korean version of the Western Ontario and McMaster osteoarthritis index (K-WOMAC), patient global assessment (PGA), and the European quality of life five dimension five level scale (EQ-5D-5 L). Safety will be assessed by monitoring adverse events at each visit. Follow-up measurements will be performed at 12 weeks after baseline measurements. DISCUSSION: This trial will provide evidence on the efficacy and safety of electrical moxibustion as a treatment for KOA. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03287570 . Registered on 19 September 2017.

[The design and application of a moxibustion instrument with less harmful smoke and direction adjustment].

The design of a clip-on moxibustion instrument which could adjust the directions and absorb harmful granules of moxa smoke was introduced in this paper. It was designed to solve the problems in home health care and clinical treatment, such as the inconvenience of adjustment of moxibustion directions and temperature, more dust and granules of moxa smoke and inconvenience of moxibustion placement. The main part of moxibustion instrument was made up of moxibustion box, bracket and base clamp. The moxibustion box could fix moxa stick and absorb smoke granules; the bracket could be twisted to adjust the direction of moxibustion box; the base clamp was aimed to fix moxibustion box on the edge of the object to save space. This moxibustion instrument could be used for various indications of moxibustion, especially in the joints or body parts with less muscles; and it can significantly enhance the pertinence and safety of moxibustion, and reduce the labor intensity. This moxibustion instrument is original and unique, simple and reasonable, easy to operate, with low cost and good effect, which will increase new vitality for the popularization and development of moxibustion.

[Development of non-traumatic-pain acupuncture-moxibustion apparatus and its industrialization].

In order to alleviate the discomforts induced by the invasive manipulation of acupuncture, improve the acceptability of acupuncture-moxibustion therapy and promote the application of it in healthcare, the research team developed the non-traumatic-pain acupuncture-moxibustion apparatus for disease treatment and prevention as well as healthcare, such as crude herbal moxibustion plus cupping device (cupping device), the healthcare cloth for warming the governor vessel (healthcare cloth) and the governor vessel intelligent diagnosis apparatus (diagnosis apparatus). Cupping device was developed through the integration of crude herb extract for moxibustion and silica gel, which is used specially on the governor vessel, Jiaji (EX-B2) and the bladder meridian of food-taiyang for chronic disorders and healthcare. The healthcare cloth was prepared with hi-tech thermal material and on the basis of yang nourishment of the governor vessel, acting on warming yang, benefiting qi and promoting qi circulation. It is applicable for the people of 7 body constitutions, such as neutral constitution, qi deficiency constitution and yang deficiency constitution to regulate the body constitution. The diagnosis apparatus integrates the functions of diagnosis and treatment as well as data analysis, implying the future of "internet+" medical development of TCM. The industrialization of non-traumatic-pain acupuncture-moxibustion apparatus should be guided under the national policy and use fully the advantage of internet so as to maintain and promote the people's health through the industry-university-research cooperation.

[Application of self-developed moxibustion thermometer in experiment teaching].

In order to improve the teaching quality of moxibustion experiment, a moxibustion thermometer was self-developed to monitor the real-time and continuous data of moxibustion temperature at different time points during the experiment. After teacher's explanation and demonstration of experiment process, the students used the moxibustion thermometer to monitor the change of temperature data and extended the experiment design. In the process of experiment class, the students found the temperature of the object tested increased rapidly, arrived at the highest temperature and slowly reduced. In addition, with learned knowledge, the students were able to design the feasible experiment scheme. The self-developed moxibustion thermometer operates smoothly in actual teaching, with stable experiment data and less experiment error, which obtained satisfactory teaching effect.

A Trial Study of Moxibustion with a Warming Needle on Edema.

Edema is an accumulation of an excessive amount of watery fluid in cells or intercellular tissues. In order to examine the effects of acupuncture and moxibustion on edema, seven subjects were randomly divided into three groups, that was a Control group, an Acupuncture group (Acp), and an acupuncture and moxibustion group (Acp-Mox). After sitting for 60 minutes keeping their bodies still, the Acp and Acp-Mox subjects were administered acupuncture or acupuncture/moxibustion on the points of Zusanli (ST-36) and Sanyinjiao (SP-6), separately as against the Control group who only lied on the bed after modelization. After modelization at 60 minutes, the skin temperature and blood flow of all the groups were significantly lower in blood flow when compared with premodelization. But shortly after the procedure at 80 minutes, skin temperature in the Acp and Acp-Mox groups were significantly increased when compared with premodelization (vs. 60 minutes, p < 0.05). Moreover, the skin temperature and blood flow of the Acp-Mox group were significantly increased as compared to both the Control and the Acp group at the 80-minute time point. These results indicate that Acp and Mox-Acp could relieve edematous conditions significantly, especially the procedure of moxibustion with warming needle, was effective in improving edema which is often accompanied with cold intolerance and would be a recommended and superior therapy for edema.

Safety recommendations for moxa use based on the concentration of noxious substances produced during commercial indirect moxibustion.

BACKGROUND: Moxibustion therapy has been used historically for thousands of years and there are many clinical trials supporting its efficacy and effectiveness for various conditions. Moxa smoke has been a major reason for avoiding moxibustion due to its smell and potential risks to the human body. METHODS: 10 units of commercial indirect moxa (CIM) from six manufacturers (A-F) were burnt in a 2.5×2.5×2.5 m chamber without ventilation, and concentrations of carbon oxides (CO and CO2), nitrogen oxides (NOx), and volatile organic compounds (VOCs) from the indoor air samples were measured. RESULTS: For brands A, B, C, D, E, and F, respectively, relative to baseline values, we observed an increase in CO (from 0.002 to 0.007, 0.006, 0.005, 0.006, 0.005, and 0.006 parts per billion (ppb)), NOx (from 0.009 to 0.051, 0.025, 0.015, 0.050, 0.019, and 0.020 ppb), and total VOCs (TVOC; from 48.06 to 288.83, 227.93, 140.82, 223.22, 260.15, and 161.35 µg/m3), while the concentration of CO2 was not elevated. Each CIM brand demonstrated different VOC emission characteristics, which could be divided into three groups. On average, we estimated that 20 units of CIM or 2.41 g moxa floss would need to be combusted in order to exceed the safe levels set by Korean environmental law. This limit is likely to be greater in the case of a larger room or use of ventilation. CONCLUSIONS: Despite increased CO/NOx/VOC concentrations, overall levels remained within safe limits. These findings may help clinicians to maintain safe moxibustion treatment conditions to help keep both patients and clinicians safe from the pollutants generated by moxa combustion.

Efficacy of Warm Needle Moxibustion on Lumbar Disc Herniation: A Meta-Analysis.

BACKGROUND: Clinical studies on the efficacy of warm needle moxibustion to treat lumbar disc herniation are increasing, while studies on the assessment of its efficacy are still lacking. OBJECTIVE: To assess the clinical effect of warm needle moxibustion on lumbar disc herniation. METHODS: We searched relevant trials that compared warm needle moxibustion with other methods for lumbar disc herniation from 9 databases. RESULTS: Warm needle moxibustion showed statistical significance efficiency rate compared with acupuncture and manipulation but had a similar rate with nonsteroidal anti-inflammatory drugs (NSAIDs). It showed a statistically significanty excellent rate when compared with acupuncture and manipulation but had a similar rate with NSAIDs. Regarding Japanese Orthopedic Association scores, it showed statistical significance with acupuncture and manipulation, but the rate was similar with Chinese medicine and NSAIDs. Regarding visual analog scale score, it demonstrated statistical significance when compared with acupuncture, manipulation, and NSAIDs but had a similar rate with Chinese medicine. CONCLUSION: Warm needle moxibustion is superior to acupuncture and manipulation in terms of efficiency rate, excellent rate, and controlling of pain for lumbar disc herniation, but it is similar when compared with NSAIDs and Chinese medicine.

[Discussion on some issues of medicated thread moxibustion of Zhuang ethnic group].

The exploring,standardizing and summarizing of the medicated thread moxibustion of Zhuangethnic group are introduced. It is found that there are something deficiency needed to be improved about its system. Thus,we propose a few suggestions and supplements including the definition,the preparation and grasp of the threads,firing and moxibustion manipulation,its intensity of operation,the specification of the threads and moxibustion frequency. We hope that it will provide reference to the improvement of its system.

[Needle-knife combined with pseudo-ginseng-cake moxibustion for primary knee osseous arthritis of blood stasis syndrome:a randomized controlled trial].

OBJECTIVE: To observe the clinical efficacy differences between needle-knife combined with pseudo-ginseng-cake moxibustion and oral administration of western medication for primary knee osseous arthritis (PKOA) of blood stasis syndrome. METHODS: Sixty cases of PKOA of blood stasis syndrome were randomly assigned to an observation group and a control group. Patients in the observation group (30 patients, 38 knees) were treated with needle-knife combined with pseudo-ginseng-cake moxibustion, while patients in the control group (30 patients, 36 knees) were oral administration of western medication. The treatment was given three weeks continuously. The knee osteoarthritis outcome score (KOOS) was adopted to observe the knee pain, symptoms and stiffness, daily life, sport and entertainment function, daily life quality score and total score in the two groups before and after treatment. The follow-up visit was performed two months after the treatment to evaluate the long-term efficacy. RESULTS: The total effective rate was 97.4% (37/38) in the observation group, which was significantly superior to 77.8% (28/36) in the control group (P<0.05). Each item of KOOS was increased in the observation group after treatment and follow-up visit (P<0.05, P<0.01); the KOSS in the control group was also increased (all P<0.01) after treatment, and daily life and daily life quality score of knee in the follow-up visit were significantly increased (both P<0.01). The scores other than sport and entertainment function score in the observation were significantly higher than those in the control group (all P<0.01). CONCLUSIONS: The needle-knife combined with pseudo-ginseng-cake moxibustion could significantly improve the symptoms of PKOA of blood stasis syndrome, which was superior to oral administration of western medication alone and had better long-term effects.